MRN : 678097-0 Reference No.
: Lab ID : 9491673
Name : JUSTUS EDWIN DOB : 15-05-1981
Gender : Male Mobile No : 0543233079
Age : 41 Y Reg. Date : 22-06-2022 11:32:53
Location : Life Medical Diagnostics-Abu Dhabi Collection Date : 22-06-2022 11:32:53
Ref. By Dr. : Verified Date : 22-06-2022 13:50:14
EID No : Passport No : U0456809
:
Molecular Biology
Test Result Reference Range Methodology
COVID-19 by RT-PCR Negative Negative ORF1 and N genes
detection by RT-PCR
(Solgent/DiaPlexQ assay )
-- Specimen type: Nasopharyngeal or/Oropharyngeal swab on Viral Transport Media.
-- Test Methodology:
COVID-19 Detection Kit is an in vitro diagnostic assay intended for Real-time PCR based detection of new SARS-CoV-2 RNA virus for
confirmation of COVID-19 disease in patients with suspect viral infection.
--Results Interpretation:
- Detected samples are reported as: "Positive".
- Not detected samples are reported as : "Negative".
--Limitations:
1.As with all diagnostic tests, a definitive clinical diagnosis should not be based on the result of a single test, but should only be made after all
clinical and laboratory findings have been evaluated. Collection of multiple specimens from the same patient may be necessary to detect the
virus.
2.A false negative result may occur if a specimen is improperly collected, transported or handled. False negative results may also occur if
amplification inhibitors are present in the specimen or if organisms present in the specimen is in a concentration below the assay's limit of
detection.
3.This test cannot rule out diseases caused by other bacterial or viral pathogens.
-- Disclaimer: This assay has been validated and its performance characteristics have been determined by Life Medical Diagnostic Centre in the
Emirate of Abudhabi; Department of Molecular Biology.
--REFERENCES:
1.Clinical Laboratory Standards Institute (CLSI), "Collection, Transport, Preparation and Storage of Specimens for Molecular Methods:
Proposed Guideline," MM13-A
2.Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19).
https://www.cdc.gov/coronavirus/2019-ncov/lab/lab biosafety-guidelines.html
End of Report
Reviewed By: Dr. Tahani Amer Approved By : Dr. Rania Bedair,MD,PhD
Lab Director Consultant Pathologist
GD19216 Final Report GD36605
Page 1 of 1
THIS IS A SYSTEM GENERATED REPORT AND DOES NOT REQUIRE PHYSICAL SIGNATURE
Printed By: Printed Date: 22/06/2022 13:51
